[1]
Juniarto, A.Z., Noppe, G., Maharani, N., van den Akker, E., Susanto, R., MH Faradz, S., H. de Jong, F. and L.S. Drop, S. 2014. Salivary 17-hydroxyprogesterone (17-OHP) and androstenedione in monitoring efficacy of treatment among Indonesian Congenital Adrenal Hyperplasia Patients. Journal of the ASEAN Federation of Endocrine Societies. 27, 2 (May 2014), 203.